Celanese Corporation (CE)
Official siteBASIC MATERIALS • CHEMICALS • NYSE
Market Cap: $5.64B
Last updated: Nov 17, 2026 at 11:05 AM ET
Celanese Corporation (CE) Earnings: Report Dates and Results
Celanese (CE) is expected to report earnings on Feb 15, 2027. In the quarter ended Sep 30, 2026, Celanese reported EPS of $1.65, above the $1.52 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CE has an expected report date of Feb 15, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 89.6% above the $0.67 reported for the quarter ended Dec 31, 2025.
CE Earnings Call
The latest CE earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, CE beat 28, missed 11 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $2.56B, up 5.8% from $2.42B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $1.65 | $1.52 | $1.36 - $1.72 | +8.55% | Beat | +23.1% | 17 | 1 up, 1 down | Nov 2, 2026 | $2.56B |
| Jun 30, 2026 | $2.45 | $2.21 | $1.97 - $2.35 | +10.86% | Beat | +70.1% | 15 | 2 up, 1 down | Aug 4, 2026 | $2.75B |
| Mar 31, 2026 | $0.85 | $0.90 | $0.78 - $1.23 | -5.56% | Miss | +49.1% | 15 | 6 up, 1 down | May 5, 2026 | $2.34B |
| Dec 31, 2025 | $0.67 | $0.91 | $0.81 - $0.95 | -26.37% | Miss | -53.8% | 14 | 0 up, 3 down | Feb 17, 2026 | $2.20B |
| Sep 30, 2025 | $1.34 | $1.22 | $1.11 - $1.33 | +9.84% | Beat | -45.1% | 16 | 2 up, 7 down | Nov 6, 2025 | $2.42B |
| Jun 30, 2025 | $1.44 | $1.40 | $1.30 - $1.49 | +2.86% | Beat | -39.5% | 16 | 2 up, 2 down | Aug 11, 2025 | $2.53B |
| Mar 31, 2025 | $0.57 | $0.39 | $0.25 - $0.58 | +46.15% | Beat | -72.6% | 17 | 3 up, 4 down | May 5, 2025 | $2.39B |
| Dec 31, 2024 | $1.45 | $1.20 | $1.08 - $1.25 | +20.68% | Beat | -35.3% | 16 | 0 up, 9 down | Feb 18, 2025 | $2.36B |
| Sep 30, 2024 | $2.44 | $2.85 | $2.71 - $3.09 | -14.39% | Miss | -2.4% | 18 | 0 up, 0 down | Nov 4, 2024 | $2.65B |
| Jun 30, 2024 | $2.38 | $2.74 | $2.38 - $3.02 | -13.14% | Miss | +9.7% | 19 | 0 up, 1 down | Aug 1, 2024 | $2.65B |
| Mar 31, 2024 | $2.08 | $1.91 | $1.76 - $2.06 | +8.90% | Beat | +3.5% | 20 | 2 up, 0 down | May 8, 2024 | $2.61B |
| Dec 31, 2023 | $2.24 | $2.31 | $2.08 - $2.41 | -3.03% | Miss | +55.6% | 19 | 0 up, 0 down | Feb 20, 2024 | $2.56B |
| Sep 30, 2023 | $2.50 | $2.23 | $2.00 - $2.48 | +12.11% | Beat | -36.5% | 18 | 5 up, 1 down | Nov 6, 2023 | $2.72B |
| Jun 30, 2023 | $2.17 | $2.48 | $2.16 - $2.80 | -12.50% | Miss | -56.5% | 21 | 0 up, 0 down | Aug 7, 2023 | $2.79B |
| Mar 31, 2023 | $2.01 | $1.63 | $1.34 - $1.77 | +23.31% | Beat | -63.7% | 20 | 1 up, 0 down | May 9, 2023 | $2.85B |
| Dec 31, 2022 | $1.44 | $1.66 | $1.24 - $1.85 | -13.25% | Miss | -70.7% | 21 | 0 up, 0 down | Feb 23, 2023 | $2.35B |
| Sep 30, 2022 | $3.94 | $3.97 | $3.32 - $4.42 | -0.76% | Miss | -18.3% | 23 | 0 up, 1 down | Nov 3, 2022 | $2.30B |
| Jun 30, 2022 | $4.99 | $4.56 | $4.17 - $4.92 | +9.43% | Beat | -0.6% | 21 | 6 up, 1 down | Jul 28, 2022 | $2.49B |
| Mar 31, 2022 | $5.54 | $4.51 | $4.31 - $4.70 | +22.84% | Beat | +60.1% | 21 | 3 up, 0 down | Apr 28, 2022 | $2.54B |
| Dec 31, 2021 | $4.91 | $5.06 | $4.96 - $5.29 | -2.96% | Miss | +134.9% | 22 | 5 up, 0 down | Jan 27, 2022 | $2.27B |
| Sep 30, 2021 | $4.82 | $4.73 | $4.51 - $4.98 | +1.90% | Beat | +147.2% | 20 | 1 up, 1 down | Oct 21, 2021 | $2.27B |
| Jun 30, 2021 | $5.02 | $4.46 | $4.00 - $5.15 | +12.56% | Beat | +286.2% | 20 | N/A | Jul 22, 2021 | $2.20B |
| Mar 31, 2021 | $3.46 | $3.01 | $2.59 - $3.11 | +14.95% | Beat | +51.1% | 20 | N/A | Apr 22, 2021 | $1.80B |
| Dec 31, 2020 | $2.09 | $1.72 | $1.50 - $2.19 | +21.51% | Beat | +5.0% | 20 | N/A | Jan 28, 2021 | $1.59B |
| Sep 30, 2020 | $1.95 | $1.69 | $1.59 - $1.83 | +15.38% | Beat | -22.9% | 21 | N/A | Oct 25, 2020 | $1.41B |
| Jun 30, 2020 | $1.30 | $1.05 | $0.78 - $1.30 | +23.81% | Beat | -45.4% | 21 | N/A | Jul 28, 2020 | $1.19B |
| Mar 31, 2020 | $2.29 | $2.22 | $1.81 - $2.63 | +3.15% | Beat | -12.6% | 18 | N/A | Apr 27, 2020 | $1.46B |
| Dec 31, 2019 | $1.99 | $2.12 | $1.77 - $2.28 | -6.13% | Miss | -16.4% | 20 | N/A | Jan 30, 2020 | $1.43B |
| Sep 30, 2019 | $2.53 | $2.50 | $2.27 - $2.60 | +1.20% | Beat | -14.5% | 21 | N/A | Oct 21, 2019 | $1.59B |
| Jun 30, 2019 | $2.38 | $2.35 | $2.30 - $2.65 | +1.28% | Beat | -17.9% | 20 | N/A | Jul 22, 2019 | $1.59B |
| Mar 31, 2019 | $2.62 | $2.41 | $2.16 - $2.77 | +8.71% | Beat | -6.1% | 20 | N/A | Apr 22, 2019 | $1.69B |
| Dec 31, 2018 | $2.38 | $2.40 | $2.30 - $2.70 | -0.83% | Miss | +20.2% | 20 | N/A | Jan 28, 2019 | $1.69B |
| Sep 30, 2018 | $2.96 | $2.74 | $2.56 - $2.90 | +8.03% | Beat | +53.4% | 18 | N/A | Oct 18, 2018 | $1.77B |
| Jun 30, 2018 | $2.90 | $2.43 | $2.26 - $2.83 | +19.34% | Beat | +62.0% | 20 | N/A | Jul 19, 2018 | $1.84B |
| Mar 31, 2018 | $2.79 | $2.33 | $2.07 - $2.50 | +19.74% | Beat | +54.1% | 18 | N/A | Apr 16, 2018 | $1.85B |
| Dec 31, 2017 | $1.98 | $1.87 | $1.80 - $2.09 | +5.88% | Beat | +30.3% | 18 | N/A | Jan 25, 2018 | $1.59B |
| Sep 30, 2017 | $1.93 | $1.92 | $1.78 - $1.99 | +0.52% | Beat | +15.6% | 17 | N/A | Oct 16, 2017 | $1.57B |
| Jun 30, 2017 | $1.79 | $1.76 | $1.67 - $1.84 | +1.70% | Beat | +12.6% | 17 | N/A | Jul 24, 2017 | $1.51B |
| Mar 31, 2017 | $1.81 | $1.72 | N/A | +5.23% | Beat | -1.1% | N/A | N/A | Apr 17, 2017 | $1.47B |
| Dec 31, 2016 | $1.52 | $1.52 | N/A | 0.00% | In line | +21.6% | N/A | N/A | Feb 1, 2017 | $1.31B |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $4.02, down 51.9% from the year before. It was $6.61 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $4.02 | -51.9% |
| Dec 31, 2024 | $8.35 | -6.4% |
| Dec 31, 2023 | $8.92 | -43.9% |
| Dec 31, 2022 | $15.91 | -12.6% |
| Dec 31, 2021 | $18.21 | +138.7% |
| Dec 31, 2020 | $7.63 | -19.9% |
| Dec 31, 2019 | $9.52 | -13.7% |
| Dec 31, 2018 | $11.03 | +46.9% |
| Dec 31, 2017 | $7.51 | +13.6% |
| Dec 31, 2016 | $6.61 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,700 words across 17 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,749 | 17 | |
| 2026Q2 | Jun 30, 2026 | 4,929 | 18 | |
| 2026Q1 | Mar 31, 2026 | 6,540 | 18 | |
| 2025Q4 | Dec 31, 2025 | 3,906 | 13 | |
| 2025Q3 | Sep 30, 2025 | 5,451 | 18 | |
| 2025Q2 | Jun 30, 2025 | 6,492 | 18 | |
| 2025Q1 | Mar 31, 2025 | 7,341 | 20 | |
| 2024Q4 | Dec 31, 2024 | 5,930 | 19 |
2026Q3 Earnings Call
Opening remarks
William Cunningham Vice President of Investor Relations Thanks, Daryl, and welcome to the Celanese Corporation Third Quarter 26 Earnings Conference Call. My name is Bill Cunningham, Vice President of Investor Relations. With me today on the call are Scott A. Richardson, President and Chief Executive Officer, and Chuck Kyrish, Chief Financial Officer. Celanese distributed its third-quarter earnings release via Business Wire and posted prepared comments, as well as a presentation, on our Investor Relations website yesterday afternoon. As a reminder, we will discuss non-GAAP financial measures today. You can find definitions of these measures, as well as reconciliations to the comparable GAAP measures, on our website. Today's presentation will also include forward-looking statements. Please review the cautionary language regarding forward-looking statements, which can be found at the end of both the press release and the prepared comments. Form 8-K reports containing all of these materials have also been submitted to the SEC. With that, Daryl, let's go ahead and open it up for questions.
Operator Operator Thank you. We will now be conducting a question-and-answer session. Our first questions are coming from the line of Ghansham Panjabi with Baird. Please proceed with your questions.
Ghansham Panjabi Analyst Thank you, operator. Good morning, everybody. I guess first off, in terms of the EBITDA underpinning your $700 million to $800 million free cash flow assumption for next year, can you just give a sense of what you are assuming in terms of underlying assumptions? Is it basically some version between 2025 and 2026, adjusting for the cost savings? What is your initial view on that?
Scott A. Richardson CEO Yes. Thanks, Ghansham. Let me start, and then I will turn it to Chuck to talk a little bit about how he is thinking about free cash flow generation. The team is really being very intentional about how we engage with customers right now to finish the year, so we can plan and position for what is still some uncertainty as we go into 2027. I think Acetyl Chain continues to focus on contracting business, and with some of the benefits that we have seen from the reliability of supply, getting that business contracted for 2027. Engineered Materials is being really deliberate and intentional with how we build the pipeline with high quality, particularly in some of these growth segments. With that, when you combine that focus on the top line with the cost actions that we called out, pushing approximately $100 million between costs and interest next year, we do feel like we can make 2026 a base that we can build off of going into 2027.
Chuck Kyrish CFO Yep. Thanks.
Frequently Asked Questions About CE
When is Celanese's next earnings date?
Celanese's next earnings report is expected for Feb 15, 2027.
Did CE beat earnings estimates last quarter?
Yes. Celanese reported EPS of $1.65 for the quarter ended Sep 30, 2026, above the $1.52 estimate, a 8.55% surprise.
What EPS do analysts expect from CE next quarter?
The consensus EPS estimate for Celanese for the quarter ending Dec 31, 2026 is $1.27 from 22 analysts, with estimates from $1.10 to $1.46.
How often does CE beat earnings estimates?
Celanese beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +8.38%.
CE pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors